Insulin-like growth factor binding protein 1 (IGFBP-1) antibody and antigen (hapten, BSA/OVA conjugated)
Diagnostic anti-Insulin-like growth factor binding protein 1 (IGFBP-1) antibodies (anti-Insulin-like growth factor binding protein 1, anti-IGFBP-1) and diagnostic hapten-carrier conjugates BSA-Insulin-like growth factor binding protein 1 (IGFBP-1), OVA-Insulin-like growth factor binding protein 1 (IGFBP-1), KLH-Insulin-like growth factor binding protein 1 (IGFBP-1) antigens for Hormone disorders IGFBP-1 detection in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-SMT-IGFBP-1-Ag01 | BSA-Insulin-like growth factor binding protein 1 (IGFBP-1) / OVA-Insulin-like growth factor binding protein 1 (IGFBP-1) | 756 |
GMP-SMT-IGFBP-1-Ag02 | BSA-Insulin-like growth factor binding protein 1 (IGFBP-1) / OVA-Insulin-like growth factor binding protein 1 (IGFBP-1) | 756 |
GMP-SMT-IGFBP-1-Ab01 | Anti-human Insulin-like growth factor binding protein 1 (IGFBP-1) mouse monoclonal antibody (mAb) | 1953 |
GMP-SMT-IGFBP-1-Ab02 | Anti-human Insulin-like growth factor binding protein 1 (IGFBP-1) human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-SMT-IGFBP-1-Ag01, GMP-SMT-IGFBP-1-Ag02 |
Product Name | BSA-Insulin-like growth factor binding protein 1 (IGFBP-1) / OVA-Insulin-like growth factor binding protein 1 (IGFBP-1) |
Target/Biomarker | Insulin-like growth factor binding protein 1 (IGFBP-1) |
Expression platform | Synthetic |
Isotypes | NA |
Bioactivity validation | Insulin-like growth factor binding protein 1 (IGFBP-1) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in IGFBP-1 level test of Hormone disorders (Pregnancy) and related syndrome evaluation. |
Tag | NA |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Insulin-like growth factor binding protein 1 (IGFBP-1) / OVA-Insulin-like growth factor binding protein 1 (IGFBP-1) is Synthetic. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Competitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-SMT-IGFBP-1-Ab01 |
Product Name | Anti-human Insulin-like growth factor binding protein 1 (IGFBP-1) mouse monoclonal antibody (mAb) |
Target/Biomarker | Insulin-like growth factor binding protein 1 (IGFBP-1) |
Expression platform | Hybridoma |
Isotypes | Mouse IgG |
Bioactivity validation | Insulin-like growth factor binding protein 1 (IGFBP-1) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in IGFBP-1 level test of Hormone disorders (Pregnancy) and related syndrome evaluation. |
Tag | mFc |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Insulin-like growth factor binding protein 1 (IGFBP-1) / OVA-Insulin-like growth factor binding protein 1 (IGFBP-1) is Synthetic. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-SMT-IGFBP-1-Ab02 |
Product Name | Anti-human Insulin-like growth factor binding protein 1 (IGFBP-1) human monoclonal antibody (mAb) |
Target/Biomarker | Insulin-like growth factor binding protein 1 (IGFBP-1) |
Expression platform | Hybridoma |
Isotypes | Mouse IgG |
Bioactivity validation | Insulin-like growth factor binding protein 1 (IGFBP-1) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in IGFBP-1 level test of Hormone disorders (Pregnancy) and related syndrome evaluation. |
Tag | mFc |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Insulin-like growth factor binding protein 1 (IGFBP-1) / OVA-Insulin-like growth factor binding protein 1 (IGFBP-1) is Synthetic. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Competitive immunoassay validation (Competitive ELISA),Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Premature rupture of membranes (PROM) is essential to maintain the pregnancy. Various diagnosis method has been used to diagnose PROM. Insulin-like growth factor binding protein-1 (IGFBP-1) is present in an essentially higher concentration in amniotic fluid, than in serum, cervical mucous, urine and seminal plasma. IGFBP is present in high concentration in amniotic fluid.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.